Can GLP1's Semaglutide & Tirzepatide treat PCOS
However, NPY/AGRP neurons are inhibited indirectly via a GLP1 receptor dependent activation of presynaptic GABAergic neurons (He et al., 2019

Community Experiences: Real-World Reports The Microdosing Movement Online communities have emerged around GLP-1 microdosing: Reddit r/Peptides: 1,700+ members discussing microdosing strategies Facebook groups: Multiple private groups with thousands of members TikTok trends: #GLP1Hack videos with millions of views Discord servers: Real-time support and protocol sharing Reported Motivations 66% Side effect reduction 38% Cost savings 28% Better control of blood sugar Common Protocols Reported While not medically validated, community members report using: Monday/Thursday: Twice-weekly splitting for convenience Monday/Wednesday/Friday: Three times weekly for stability Every other day: Maximum smoothing of levels Variable dosing: Higher doses on less active days Concerning Trends Problematic behaviors observed: 55% make decisions without physician consultation Many use compounded medications of uncertain quality Dose escalation beyond FDA-approved limits Combining multiple GLP-1 agonists Following influencer protocols without medical oversight A Personal Perspective When I started reading the reta research, one thing bugged me: this triple-agonist mechanism is far more complex than semaglutide, yet the dosing protocol is identical: once weekly, same as everything else

Future research should utilize PCOS-specific instruments (e.g., PCOSQ) and pre-specify psychological outcomes to enhance comparability and interpretability
fatigue Prioritize rest and sleep Engage in light physical activity, such as stretching or walking Maintain a balanced diet, including adequate protein and iron intake Consider stress-reducing techniques, like meditation or yoga 8
SKU: EPI-10MG Epithalon is investigated as a peptide-based research tool for examining cellular aging-associated signaling, chromosomal stability mechanisms, and circadian-related regulatory pathways